Niki BioSolutions, Inc.（NIKI）重大事項與業績發布
| 申報日 | 表別 | 事項 | 原文 |
|---|---|---|---|
| 2026-08-21 | 8-K | 財務報表與附件 | SEC |
| 2026-08-07 | 8-K | 其他事項 | SEC |
| 2026-07-20 | 8-K | 資產收購或處分、Item 3.03、董事與高階主管異動、章程修訂、其他事項、財務報表與附件 | SEC |
| 2026-06-10 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2026-05-14 | 6-K | CURRENT REPORT | SEC |
| 2026-03-31 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2026-03-11 | 6-K | FORM 6-K | SEC |
| 2026-03-06 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2026-02-06 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2026-01-22 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2025-10-16 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2025-10-15 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2025-10-08 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2025-10-03 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2025-09-10 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2025-07-22 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2025-04-16 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2025-01-07 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2024-12-20 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2024-12-11 | 6-K | FORM 6-K | SEC |
| 2024-11-08 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2024-11-01 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2024-08-09 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2024-05-31 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2024-04-30 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2024-03-06 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
資料來自 SEC EDGAR 的 8-K／6-K 申報。8-K 是美國國內發行人的重大事項揭露（Item 2.02 為業績發布）；6-K 是外國發行人（含 ADR）的對應形式。本站僅整理連結，原文一律在 SEC 網站。